Anti-cancer cytotoxic effects of multiwalled carbon nanotubes. 2015

Lorena Garcia-Hevia, and Rafael Valiente, and Jesus Gonzalez, and Jose Luis Fernandez-Luna, and Juan C Villegas, and Monica L Fanarraga

Recent research has opened new alternatives to traditional chemotherapy treatments using nanomaterials as cytotoxic agents. Anti-cancer nanomedicines do not require specific target sites on key proteins or genes to kill cancer cells and have radically different mechanisms to interact with the living matter. Among 1D nanomaterials, multiwalled carbon nanotubes (MWCNTs) have the intrinsic ability to bind tubulin and interfere with microtubule dynamics, mimicking the effect of traditional cytotoxic microtubule-binding agents such as paclitaxel (taxol®). Here, we review the cytotoxic properties of MWCNTs and show a direct pro-apoptotic effect of these nanomaterials in vitro in different cancer cell lines and tumor cells obtained from surgical specimens. Understanding the bio-synthetic relationship between MWCNTs and microtubules could serve to improve these nanomaterials to be used as broad spectrum antineoplastic agents in combination to traditional microtubule-binding treatments, thus avoiding drug resistance mechanisms in cancer cells.

UI MeSH Term Description Entries
D008870 Microtubules Slender, cylindrical filaments found in the cytoskeleton of plant and animal cells. They are composed of the protein TUBULIN and are influenced by TUBULIN MODULATORS. Microtubule
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D019008 Drug Resistance, Neoplasm Resistance or diminished response of a neoplasm to an antineoplastic agent in humans, animals, or cell or tissue cultures. Antibiotic Resistance, Neoplasm,Antineoplastic Drug Resistance,Drug Resistance, Antineoplastic,Antineoplastic Agent Resistance,Neoplasm Drug Resistance,Resistance, Antineoplastic Agent,Resistance, Antineoplastic Drug
D037742 Nanotubes, Carbon Nanometer-sized tubes composed mainly of CARBON. Such nanotubes are used as probes for high-resolution structural and chemical imaging of biomolecules with ATOMIC FORCE MICROSCOPY. Buckytubes,Carbon Nanotubes,Nanoribbons,Buckytube,Carbon Nanotube,Nanoribbon,Nanotube, Carbon

Related Publications

Lorena Garcia-Hevia, and Rafael Valiente, and Jesus Gonzalez, and Jose Luis Fernandez-Luna, and Juan C Villegas, and Monica L Fanarraga
May 2018, Occupational and environmental medicine,
Lorena Garcia-Hevia, and Rafael Valiente, and Jesus Gonzalez, and Jose Luis Fernandez-Luna, and Juan C Villegas, and Monica L Fanarraga
May 2005, Physical review letters,
Lorena Garcia-Hevia, and Rafael Valiente, and Jesus Gonzalez, and Jose Luis Fernandez-Luna, and Juan C Villegas, and Monica L Fanarraga
April 2005, Langmuir : the ACS journal of surfaces and colloids,
Lorena Garcia-Hevia, and Rafael Valiente, and Jesus Gonzalez, and Jose Luis Fernandez-Luna, and Juan C Villegas, and Monica L Fanarraga
September 2011, The journal of physical chemistry. A,
Lorena Garcia-Hevia, and Rafael Valiente, and Jesus Gonzalez, and Jose Luis Fernandez-Luna, and Juan C Villegas, and Monica L Fanarraga
January 2003, Journal of nanoscience and nanotechnology,
Lorena Garcia-Hevia, and Rafael Valiente, and Jesus Gonzalez, and Jose Luis Fernandez-Luna, and Juan C Villegas, and Monica L Fanarraga
December 2016, Water research,
Lorena Garcia-Hevia, and Rafael Valiente, and Jesus Gonzalez, and Jose Luis Fernandez-Luna, and Juan C Villegas, and Monica L Fanarraga
January 2019, Methods in molecular biology (Clifton, N.J.),
Lorena Garcia-Hevia, and Rafael Valiente, and Jesus Gonzalez, and Jose Luis Fernandez-Luna, and Juan C Villegas, and Monica L Fanarraga
January 2002, Physical review letters,
Lorena Garcia-Hevia, and Rafael Valiente, and Jesus Gonzalez, and Jose Luis Fernandez-Luna, and Juan C Villegas, and Monica L Fanarraga
August 2013, Environmental science & technology,
Lorena Garcia-Hevia, and Rafael Valiente, and Jesus Gonzalez, and Jose Luis Fernandez-Luna, and Juan C Villegas, and Monica L Fanarraga
June 2014, Journal of biomedical materials research. Part A,
Copied contents to your clipboard!